구독하기
연구 모델
서비스
전임상 효능 평가
Resource
Tmem119-CreERT2 Mouse
제품 견적 요청
카탈로그에서 제품을 선택하여 요청을 제출해 주세요. Cyagen 팀이 상세 정보를 제공해 드립니다.
Tmem119-CreERT2 Mouse
제품명
Tmem119-CreERT2 Mouse
제품 ID
C001826
품종 계통
C57BL/6JCya-Tmem119em2(CreERT2)/Cya
Backgroud
C57BL/6JCya
Expressing Tissues/Cells
Microglia
상태
이 마우스 계통을 논문에서 사용할 경우, “Tmem119-CreERT2 Mouse (카탈로그 번호 C001826)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
Inducible Cre Mouse Models
구매 가능한 제품 종류
연령
Genotype
성별
수량
표준 제공 조건은 최소 3마리의 이형접합(heterozygous) 보균자를 보장합니다. 동형접합(homozygous) 보균자 및/또는 특정 성별에 대한 브리딩 서비스도 제공됩니다.
가격 문의
Inducible Cre Mouse Models
기본 정보
검증 데이터
관련 자료
기본 정보
유전자명
유전자 별칭
obif
NCBI ID
염색체
Chr 5
MGI ID
Datasheet
품종 계통 설명
The TMEM119 gene encodes transmembrane protein 119 (TMEM119), also known as osteoblast-inducing factor (OBIF). It acts as an oncogene in osteosarcoma and is highly expressed in microglia. This ubiquitously expressed protein plays critical roles in various biological processes, including cell adhesion, migration, and differentiation. The TMEM119 gene encodes transmembrane protein 119 (TMEM119), also known as osteoblast-inducing factor (OBIF). It acts as an oncogene in osteosarcoma and is highly expressed in microglia. This ubiquitously expressed protein plays critical roles in various biological processes, including cell adhesion, migration, and differentiation. TMEM119 is vital for osteoblastogenesis—the differentiation of mesenchymal stem cells into bone-forming osteoblasts. It interacts with key signaling molecules like bone morphogenetic proteins (BMPs) to regulate osteoblast proliferation and differentiation, ultimately promoting bone formation and remodeling. Notably expressed in the developing nervous system, TMEM119 enhances neurite outgrowth and neuronal survival. It interacts with extracellular matrix components and growth factor signaling pathways to support the complex processes of neural network formation and function. Beyond its roles in bone formation and neurodevelopment, TMEM119 is also essential for normal spermatogenesis and late-stage testicular differentiation.
The Tmem119-CreERT2 mouse is generated via gene-editing technology by integrating a tamoxifen-inducible CreERT2 recombinase cassette into the stop codon of the murine Tmem119 gene, thereby driving its specific expression. This construction strategy ensures that the expression pattern of CreERT2 recombinase mimics that of the endogenous murine Tmem119 gene. Before tamoxifen induction, CreERT2 is confined to the cytoplasm; only after tamoxifen treatment can CreERT2 recombinase translocate into the nucleus to exert its genetic recombination function. When this strain is crossed with mice containing loxP sites, tamoxifen induction triggers Cre-mediated sequence recombination between loxP sites specifically in microglia. Tmem119-CreERT2 mice are applicable for researching the functions of resident microglia in the central nervous system, as well as bone development, osteoblast differentiation, and osteosarcoma.
변형 전략
The TAA stop codon was replaced with P2A-CreERT2 cassette.

Figure 1. Gene editing strategy of Tmem119-CreERT2 mice.
검증 데이터
1. Method
Tmem119-CreERT2 mice were mated with Rosa26-LSL-tdTomato mice to generate double-allele heterozygous offspring. When the offspring reached a certain age (in weeks), they were induced via intraperitoneal injection of a specific dose of tamoxifen. CreERT2-mediated recombination, triggered by tamoxifen (Tam) induction, results in tdTomato protein expression in Cre-positive cells of the offspring. Seven days after completion of induction, brain tissues (hippocampus, cerebral cortex) of the offspring were collected, and Cre recombinase-mediated fluorescence was detected via immunofluorescence staining.
2. Group
Cre+Tam+ (G1): Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5 day, 200 mg/kg/day (i.p)
Cre+Tam+ (G2): Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5+5 day, 200 mg/kg/day (i.p)
Cre+Tam+ (G3): Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5 day, 100 mg/kg/day (i.p)
Cre+Tam+ (G4): Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5+5 day, 100 mg/kg/day (i.p)
Cre+Tam-: Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5 day, Coin oil, (i.p)
Cre+Tam-: Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5+5 day, Coin oil, (i.p)
Cre+: Tmem119-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+]; 5 day, 200 mg/kg/day (i.p)
*5+5 day: Intraperitoneal injection for 5 consecutive days, followed by a 1-day interval, then another 5 days of injection.
3. Result
(1)Expression of Cre recombinase in the hippocampus
① Histological analysis showed green fluorescent signals in the hippocampus of mice in the experimental groups (G1–G4), indicating Cre recombination had occurred in these tissues. A large number of red fluorescent signals were also detected in the hippocampus, with most overlapping with green fluorescence, confirming that Cre recombination occurred in IBA1+ microglia in the model.
② Satisfactory recombination efficiency was achieved under the G3 induction condition, while G2 showed slightly higher efficiency than the other three experimental groups. Therefore, the G2 induction protocol is recommended when experimental conditions permit.
③ Some green background fluorescence was observed in brain tissues, with non-specific staining detected in structures such as blood vessels. In the hippocampus of the control and blank groups, abundant red fluorescence and a small amount of green fluorescence were observed; the latter is presumed to be non-specific staining & background fluorescence.

Figure 2. Expression of Cre recombinase in the hippocampus after tamoxifen induction.
(2)Expression of Cre recombinase in the cerebral cortex
① Histological analysis revealed green fluorescent signals in the cerebral cortex of mice in the experimental groups (G1–G4), indicating Cre recombination had occurred in these tissues. A large number of red fluorescent signals were also detected in the cerebral cortex, with most overlapping with green fluorescence, confirming that Cre recombination occurred in IBA1+ microglia in the model.
② Satisfactory recombination efficiency was achieved under the G3 induction condition, while G2 showed slightly higher efficiency than the other three experimental groups. Therefore, the G2 induction protocol is recommended when experimental conditions permit.
③ Some green background fluorescence was observed in brain tissues, with non-specific staining detected in structures such as blood vessels. In the cerebral cortex of the control and blank groups, abundant red fluorescence and a small amount of green fluorescence were observed; the latter is presumed to be non-specific staining & background fluorescence.

Figure 3. Expression of Cre recombinase in the cerebral cortex after tamoxifen induction.
4. Summary
In the Tmem119-CreERT2 mouse model, the expression of Cre recombinase after tamoxifen induction is mainly localized to IBA1-expressing microglia, with good model specificity.
Recommended induction dose and sampling time: A continuous administration of tamoxifen (TAM) at a dose of 100 mg/kg/day for 5 days, followed by sampling 7 days after induction, can achieve satisfactory recombination efficiency. If experimental conditions permit, the induction dose can be appropriately increased to 200 mg/kg/day, or the induction duration can be adjusted to 10 days.
Abnormalities in tissues such as the ovary, spleen, and abdominal cavity may occur in Tmem119-CreERT2 mice after tamoxifen induction. Internal validation has not yet found a correlation between these abnormalities and variables such as induction duration, induction dose, sex, or genotype. The specific mechanism underlying these abnormalities remains unclear. Therefore, it is recommended to closely monitor abnormal manifestations in mice during the use of this model and adjust the experimental strategy on time.
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.
